Welcome to our dedicated page for Skinhealth Systems SEC filings (Ticker: SKIN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SkinHealth Systems Inc. filings document the regulatory record for a Nasdaq-listed medical aesthetics company formerly known as The Beauty Health Company. The filings identify its Class A common stock, operating and financial results, non-GAAP reconciliations, and material-event disclosures tied to quarterly and annual reporting.
Its SEC record also includes proxy materials for annual stockholder voting, board and committee governance, director appointments, officer departures, compensatory arrangements, capital-structure disclosures and shareholder voting matters. These filings provide the formal disclosure framework for the company behind Hydrafacial, SkinStylus and related professional skin-health offerings.
SkinHealth Systems Inc. director Edward Scott Beattie filed an initial Form 3, which is a statement of beneficial ownership required when someone becomes an insider. The filing shows no reported transactions, no derivative positions, and no listed holdings at this time.
SkinHealth Systems Inc. director Edward Scott Beattie filed an initial Form 3, which is a statement of beneficial ownership required when someone becomes an insider. The filing shows no reported transactions, no derivative positions, and no listed holdings at this time.
SkinHealth Systems Inc. director Sachin Mahavir Shridharani filed an initial Form 3 reporting his equity position in the company. The filing shows a direct holding of 1,500 shares of Class A Common Stock. This is a disclosure of existing ownership rather than a new buy or sell transaction.
SkinHealth Systems Inc. director Sachin Mahavir Shridharani filed an initial Form 3 reporting his equity position in the company. The filing shows a direct holding of 1,500 shares of Class A Common Stock. This is a disclosure of existing ownership rather than a new buy or sell transaction.
SkinHealth Systems Inc. reported that Kenneth Robert Tripp has become a reporting person as a director of the company. This Form 3 shows no reported transactions or holdings at this time, serving as an initial ownership statement now that he is subject to insider reporting rules.
SkinHealth Systems Inc. reported that Kenneth Robert Tripp has become a reporting person as a director of the company. This Form 3 shows no reported transactions or holdings at this time, serving as an initial ownership statement now that he is subject to insider reporting rules.
SkinHealth Systems Inc., formerly The Beauty Health Company, has changed its corporate name and updated its charter and bylaws to reflect a strategic focus on clinically driven, science‑backed medical aesthetics. The company will continue trading on the Nasdaq Capital Market under the ticker “SKIN.”
The Board appointed three new independent directors effective April 17, 2026: operations executive Kenneth Tripp, aesthetic medicine expert Dr. Sachin Shridharani, and global beauty and consumer brands leader E. Scott Beattie. The Board temporarily expands to 11 members and is expected to return to 9 following the 2026 annual meeting when two current directors depart.
The company highlights Hydrafacial as its flagship brand and notes an installed base of more than 36,000 devices worldwide, supported by a device‑plus‑consumables model and commercial infrastructure across North America, Europe, and Asia‑Pacific.
SkinHealth Systems Inc., formerly The Beauty Health Company, has changed its corporate name and updated its charter and bylaws to reflect a strategic focus on clinically driven, science‑backed medical aesthetics. The company will continue trading on the Nasdaq Capital Market under the ticker “SKIN.”
The Board appointed three new independent directors effective April 17, 2026: operations executive Kenneth Tripp, aesthetic medicine expert Dr. Sachin Shridharani, and global beauty and consumer brands leader E. Scott Beattie. The Board temporarily expands to 11 members and is expected to return to 9 following the 2026 annual meeting when two current directors depart.
The company highlights Hydrafacial as its flagship brand and notes an installed base of more than 36,000 devices worldwide, supported by a device‑plus‑consumables model and commercial infrastructure across North America, Europe, and Asia‑Pacific.
Millennium Management and affiliated entities reported beneficial ownership of 6,509,750 shares of The Beauty Health Company Class A common stock, representing 5.1% of the class. The filing is a joint Schedule 13G dated 04/17/2026 and states these shares are held by entities subject to voting control and investment discretion by Millennium Management LLC and related managers.
Beauty Health Co executive Sheri Lewis, the CSO and COO, reported a tax-related share disposition. On April 9, 2026, 24,904 shares of Class A common stock, valued at $0.92 per share, were withheld by the company to cover taxes on vesting restricted stock units.
After this withholding, Lewis directly holds 1,584,620 shares of Class A common stock. A footnote clarifies that this was solely to satisfy tax withholding requirements and does not represent an open-market sale of shares.
Beauty Health Co Chief Financial Officer Michael P. Monahan had 26,776 shares of Class A Common Stock withheld by the company to cover tax obligations on vested restricted stock units. The shares were valued at $0.92 per share for this tax-withholding transaction.
After this non-market disposition, which the company states does not represent a sale, Monahan directly holds 1,987,637 shares of Beauty Health Co Class A Common Stock.
Malha Pedro Bruno Ferreira reported acquisition or exercise transactions in this Form 4 filing.
Beauty Health Co reported that President and CEO Pedro Bruno Ferreira Malha received a grant of 2,654,867 restricted stock units (RSUs) of Class A Common Stock as equity compensation. Each RSU represents one share of stock and vests in three equal annual installments starting on the first anniversary of the March 20, 2026 grant date, subject to continued service and certain acceleration rights.
After this award, Malha is shown as beneficially owning 4,845,251 shares of Class A Common Stock directly. The transaction was recorded at a price of $0.00 per share, reflecting that it is a compensation grant rather than an open-market purchase.
MONAHAN MICHAEL P. reported acquisition or exercise transactions in this Form 4 filing.
Beauty Health Co reported that Chief Financial Officer Michael P. Monahan received a grant of 746,681 restricted stock units of Class A Common Stock. These RSUs vest in three equal annual installments starting on March 20, 2026, contingent on continued service and certain acceleration provisions. Following this award, Monahan directly holds 2,014,413 shares or share-equivalent units, reflecting a compensation-related equity grant rather than an open-market transaction.
Menezes Ronald reported acquisition or exercise transactions in this Form 4 filing.
Beauty Health Co reported that Chief Revenue Officer Ronald Menezes received a large equity grant in the form of restricted stock units (RSUs). He was awarded 746,681 RSUs of Class A Common Stock at no purchase price as part of his compensation.
Each RSU represents a future right to receive one share of Class A Common Stock, subject to time-based vesting. The award vests in three equal installments on each of the first three anniversaries of the March 20, 2026 grant date, contingent on continued service and certain acceleration rights. Following this grant, Menezes directly owns 1,759,915 shares of the company’s Class A Common Stock.